ANZGOG 2022 Conference Review

In this review:

Protocol for the Australian OVARIAN data linkage study
OUTBACK: adjuvant chemotherapy for cervical cancer not supported
Post-treatment care for high-risk endometrial cancer needs more focus on QoL
The genomic landscape of resistance in HRD HGSOC
OCRF-007 – A new biomarker test for early detection of ovarian cancer
STRIVE: Stratification of vulvar SCC by HPV and p53 status to guide excision
High throughput discovery of synergistic drug combinations for patients with LGSOC
GZD824 demonstrates promising preclinical activity for endometrial cancer
Ipilimumab/nivolumab immunotherapy combination has activity in rare malignancies
A survey of ANZGOG oncologists on the treatment of mucinous ovarian cancer
 

Please login below to download this issue (PDF)

Subscribe